Related Experiment Video

Updated: Aug 8, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

[Conventional surgery for congestive heart failure]

Michele De Bonis1, Elisabetta Lapenna, Giovanni La Canna

  • 1Cattedra di Cardiochirurgia, Università "Vita e Salute" San Raffaele, Divisione di Cardiochirurgia, Ospedale San Raffaele, Milano. michele.debonis@hsr.it

Giornale Italiano Di Cardiologia (2006)
|May 17, 2006
PubMed

Insights

Conventional surgery offers a vital alternative for advanced heart failure when transplantation is not feasible. This review details surgical interventions for dilated cardiomyopathy, improving outcomes for many patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Background:

  • Congestive heart failure (CHF) is a significant global health issue, with increasing incidence of end-stage dilated cardiomyopathy.
  • Heart transplantation is effective but limited by donor availability, necessitating alternative treatments.
  • Conventional surgical procedures are gaining importance for managing advanced heart failure.

Purpose of the Study:

  • To review surgical strategies for end-stage heart failure due to dilated cardiomyopathy.
  • To present institutional experience with over 500 patients undergoing conventional cardiac surgery.
  • To discuss indications, outcomes, and future directions for surgical interventions in heart failure.

Main Methods:

  • Review of surgical interventions in patients with advanced dilated cardiomyopathy.
  • Procedures included myocardial revascularization, left ventricular restoration, mitral valve repair, and atrial fibrillation ablation.
  • Analysis of indications, results, and controversial aspects of surgical management.

Main Results:

  • Conventional surgical procedures are effective in managing multifactorial heart failure.
  • Specific interventions like left ventricular restoration and mitral valve repair show significant impact.
  • Surgical ablation for atrial fibrillation addresses a common comorbidity in heart failure patients.

Conclusions:

  • Conventional surgical treatments are crucial for patients with advanced dilated cardiomyopathy ineligible for heart transplantation.
  • Optimized surgical techniques offer viable options for improving quality of life and outcomes.
  • Further research and refinement of surgical approaches are warranted for heart failure management.

More Related Videos

Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...